The cholesterol controversy.

gan Tobert, J. A.
Cyhoeddwyd 1992

Lipid lowering drugs.

gan Bocanegra, T S, Tobert, J A
Cyhoeddwyd 1990

L-643.441: an H2-receptor antagonist with potent and long-lasting effects in man.

gan Henry, D A, Somerville, K W, Kitchingman, G K, Holmes, I B, Tobert, J A, Langman, M J
Cyhoeddwyd 1985

Plasma mevalonate as a measure of cholesterol synthesis in man.

gan Parker, T S, McNamara, D J, Brown, C D, Kolb, R, Ahrens, E H, Alberts, A W, Tobert, J, Chen, J, De Schepper, P J
Cyhoeddwyd 1984

Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.

gan Tobert, J A, Bell, G D, Birtwell, J, James, I, Kukovetz, W R, Pryor, J S, Buntinx, A, Holmes, I B, Chao, Y S, Bolognese, J A
Cyhoeddwyd 1982

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stoppi...

gan Haynes, Richard, Jiang, Lixin, Hopewell, Jemma C, Li, Jing, Chen, Fang, Parish, Sarah, Landray, Martin J., Collins, Rory, Armitage, Jane, Collins, R., Armitage, J., Baigent, C., Chen, Z., Landray, M., Chen, Y., Jiang, L., Pedersen, T., Landray, M., Bowman, L., Chen, F., Hill, M., Haynes, R., Knott, C., Rahimi, K., Tobert, J., Sleight, P., Simpson, D., Parish, S., Baxter, A., Lay, M., Bray, C., Wincott, E., Leijenhorst, G., Skattebol, A., Moen, G., Mitchel, Y., Kuznetsova, O., MacMahon, S., Kjekshus, J., Hill, C., Lam, T.H., Sandercock, P., Peto, R., Hopewell, J.C.
Cyhoeddwyd 2013